Purpose: Intracerebral hemorrhage (ICH) is the acute manifestation of a progressive disease of the cerebral small vessels. The severity of this disease appears to influence not only risk of ICH, but also the size of the hematoma. As the burden of high blood pressure(BP)-associated alleles is associated with hypertension-related end-organ damage, we sought to determine if this burden influences ICH admission hematoma volume (AHV). Methods: Prospective study undertaken in 441 ICH patients of European ancestry (210 deep and 231 lobar intracranial hematomas). Forty-three single-nucleotide polymorphisms (SNPs) known to be associated with high BP were genotyped in Illumina610-Quad. Single-SNP association analyses with AHV were performed using linear regression. Subsequently, a genetic risk score was calculated as the sum of the products generated by multiplying, at each of the 43 loci, the number risk alleles times the reported effect of that allele on BP. The score was utilized as the independent variable of univariate and multivariate regression models for 2 outcomes: AHV and poor clinical outcome (modified Rankin Scale 3-6). Principal components analysis was utilized to account for population structure. Results: Individually assessed, no single SNP was associated with AHV. In univariate linear regression, the genetic risk score was associated with AHV in all (deep and lobar) and deep locations (Figure 1), but not in lobar hemorrhages. In multivariate regression analyses, each additional standard deviation of the genetic risk score increased mean deep AHV by 21% (or 2.7-milliliter increase, beta=0.21, standard error=0.08, p=0.01) and risk poor clinical outcome by 55% (odds ratio=1.55, 95% confidence interval 1.05-2.28, p=0.03). No significant associations were observed when considering all (deep and lobar) and lobar hemorrhages. Conclusion: In deep ICH, increasing numbers of high BP-related alleles are associated with larger AHV and poor clinical outcome.
Abstract 44: Influence of Antithrombotics on Outcome Following Subarachnoid Hemorrhage
Objective: This study seeks to investigate the impact of antithrombotics, including Aspirin, Clopidogrel, and Warfarin, on the severity of bleeding and outcomes in patients with subarachnoid hemorrhage (SAH). We hypothesize that patients with a history of antithrombotic use have a more severe injury from SAH. Methods: Two hundred twenty-eight patients admitted to the Mayo Clinic Florida consecutively between July 2008 and July 2011 were studied retrospectively. Of this group, 77 patients had a known history of antithrombotic use while 151 did not. Both aneurysmal and non-aneurysmal cases were included in the study. Each patient’s Hunt and Hess Score, Fisher Grade, modified Rankin Scale (mRS) and Glasgow Coma Scale (GCS) were evaluated. Associations between history of antithrombotic use and severity of SAH were assessed using Spearman’s test of correlation and Mann-Whitney tests. Results: There was strong evidence of higher mRS grades in patients with a history of antithrombotic use compared to other patients (Median: 3 vs. 2, P=0.001). There was no significant difference between patients with and without a history of antithrombotic use regarding SAH Fisher grade (Median: 3 vs. 3, P=0.31) and Hunt and Hess score (Median: 2 vs. 2, P=0.93). The difference in GCS score was not statistically significant (Median: 14 vs. 15, P=0.20). Conclusion: This analysis found a significant effect of previous use of antithrombotics on overall outcome following SAH. Further analysis is needed to correlate the outcomes with specific medications and investigate the role of aggressive reversal of coagulopathy on overall outcomes.
Abstract 3997: Maintainence of Stroke Certification with Telemedicine
Introduction: In May of 2010 Mayo Clinic Florida (MCF) partnered with Parrish Medical Center (PMC) in Titusville, Florida to provide remote evaluation and treatment of acute ischemic stroke patients and triage of patients for urgent transfer. PMC was initially accredited as a Joint Commission Primary Stroke Center in 2003. In the 12-month period prior to the telemedicine partnership acute neurology coverage was not continuously available, and the rt-PA utilization rate was 0.8%. Methods: Demographic data, baseline stroke severity, time of symptom onset, telemedicine diagnosis, rt-PA utilization, complications, discharge stroke severity and discharge disposition were collected prospectively. Analysis was also performed on the success of the administrative effort, including sharing of patient and statistical information, credentialing, faculty cooperation and patient satisfaction. Results: During the first 15 months of the partnership, 193 robotic telemedicine consultations were performed. The mean time from consultation request to telephone response was 3 minutes. 86 patients had a telemedicine diagnosis of stroke and 18 (21%) patients were treated with intravenous rt-PA within 3 hours of stroke onset. Among those treated with iv rt-PA, the mean time from telemedicine evaluation to rt-PA treatment was 54 minutes. The sICH rate was 0%. The median baseline NIHSS was 8.5; the median discharge NIHSS was 2. 18 patients were urgently transferred for consideration of endovascular/surgical stroke therapies. PMC was re-certified as a primary stroke center since by the joint commission in May of 2011 with no deficiencies. Conclusions: These data confirm that telemedicine can identify patients eligible for local treatment with intravenous thrombolysis or those who would benefit from urgent transfer to a comprehensive stroke center. Telemedicine can deliver stroke care at the benchmark levels required to maintain primary stroke center certification.
Abstract 3906: Comparative Effectiveness of Long-Term Outcomes of Treatment of Unruptured Intracranial Aneurysms
Introduction: The long term effectiveness of preventive intracranial treatment of unruptured aneurysms for hemorrhage and aneurysm-related morbidity and mortality has been hypothesized. No randomized trial has been done. Propensity adjusted comparison within The International Study of Unruptured Intracranial Aneurysms was undertaken to compare long-term effectiveness. Hypothesis: The purpose of this analysis was to compare the long-term outcome in the treatment cohorts (surgery and endovascular) with those of the untreated subgroup. Methods: Patients were subdivided into the initial treatment and untreated cohorts based upon observation or treatment practices in 61 centers from 1991-1998. 1691 patients were in the observational cohort, 471 were in the endovascular cohort and 1917 patients were in the surgical cohort. The cohorts were followed for a median follow-up of 9.2 years. Outcomes were determined prospectively and with central review. The data were grouped together and analyzed to determine treatment decisions. Comparison of outcomes was done using covariate adjustment and using propensity analysis where equivalent probability groups were constructed. Similar main predictors of treatment and outcome were observed. Analysis of hemorrhage, mortality and short-term and long-term morbidity and mortality were assessed. Risk-benefit ratios were also calculated. Results: Significant differences in baseline variables between treatment and observed patients were aneurysm size, symptoms, age, prior SAH or not group, geographical region, family history, hypertension and myocardial infarction history. The results show comparability of groups using the patient propensity-based score subset. Using the propensity score method, the results showed a benefit in prevention of hemorrhage by surgery and endovascular treatment versus observation (p<.01). No difference was found between endovascular versus surgery. However when procedure-related outcomes are included, no significant difference at 1 year, 5 years or 10 years in the combined aneurysm or procedure related endpoint was evident between cohorts. Conclusions: Propensity score matching to achieve comparability resulted in balanced groups. Comparison of long-term results showed that intervention demonstrated a benefit in reducing hemorrhage risk. However, peri-procedural risk negates any short-term benefit for 10 years.
Abstract 3820: Penumbra Imaging Collaborative Study (PICS): Utilization of Imaging for Patient Selection and Its Impact on Outcomes Following Penumbra System
®
Treatment
Purpose: Various imaging approaches are utilized for evaluating acute stroke patients. Despite numerous studies, there is no clear evidence that one approach is superior to another for identifying which patients will benefit from mechanical thrombectomy (MT). The PICS registry was established to determine the imaging modalities being employed to triage acute stroke patients for MT and to assess their impact on patient functional outcome. Methods: Patients were enrolled across 35 centers. For each patient, the baseline imaging modality was recorded to determine the utilization rates of noncontrast CT (NCCT), CT perfusion (CT-P), and MRI diffusion weighted imaging (DWI). All patients subsequently treated by the Penumbra System per standard of care were followed for 3 months after the procedure to assess functional outcome using the modified Rankin Scale (mRS). Results: A total of 305 patients were enrolled in this registry, of which 267 had the requisite imaging modalities used for this analysis. Of these, 49.4% were females. Mean age was 66.6 ± 15.9 years; median NIHSS score was 17.0 (IQR 12-21). The median time from stroke onset to presentation was 2.3 hours, from stroke symptom onset to arterial puncture was 4.8 hours, and from arterial puncture to end of thromboaspiration was 73.0 minutes. Post-treatment evaluation revealed that 83.5% of patients were successfully recanalized to TIMI 2/3 (from TIMI 0/1) with 43.5% achieving a 90-day mRS of 0-2. All cause mortality was 19.9% with symptomatic intracranial hemorrhage reported in 4.5% of the patients. The principal imaging modalities used for patient triage were NCCT in 61.8%, CT-P in 27.3% and DWI in 10.9% of the study population. Of the patients selected for NCCT, 42.5% were functionally independent at 90 days, whereas for CT-P and DWI, the rates were 45.9% and 42.9%, respectively. There was no significant difference between groups for patient age, baseline NIHSS, time from onset to presentation, time from arterial puncture to end of thromboaspiration. The time from stroke symptom onset to groin puncture was significantly different in the DWI cohort (p<0.0001) with a median of 4.4 hrs for NCCT, 4.8 hrs for CTP, and 6.5 hrs for DWI. There was a significant difference in % of female patients with CTP 37.0%, DWI 48.3%, and NCCT 55.2% (p=0.034). Conclusion: The type of imaging modality utilized to triage acute ischemic stroke patients for MT varies widely across the US. Based on the present findings, the imaging approach appears to have little impact on patient functional outcome after MT.
Abstract 3774: Clinical Nurse Specialists, Nurse Practitioners&Physician Assistants Roles in the care of Stroke Patients
Background: The promotion of acute stroke care is stronger now than it has ever been with hospitals being encouraged to become primary and comprehensive stroke centers (PSC & CSC). This is a hardship for some institutions due to the national shortage of American Board of Psychiatry and Neurology certified Vascular Neurologists and Emergency Medicine Physicians’ concern over independent decision making regarding thrombolysis eligibility without neurology collaboration. Hospitals and private physician practices are turning to Clinical Nurse Specialists (CNS), Nurse Practitioners (NP) and Physician Assistants (PA) to provide a continuum and maintain coordination of care in concurrence with vascular neurologists. The aim of this presentation is to identify the CNS-NP-PA roles and responsibilities. Method: An eight question, multiple choice with 3 multiple answer survey, which addressed certification, duration of stroke experience, role with CT reviewing, thrombolysis administration, and duties was sent to community and academic PSC and CSC CNS-NP-PAs from Neurovascular Education and Training in Stroke Management and Acute Reperfusion Therapy (NET SMART) program by means of a URL. Results: There were 44 respondents, NPs 65.9%, PAs 4.9% and CNS 29.2% with experience in stroke care totaling 1 to 2.9 years in 20.5%, 3 to 4.9 years in 15.9% and ≥ 5 years in 63.6%. Acute CT evaluation was completed autonomously by 10%, with radiology collaboration in 47.5%, and with neurology collaboration in 37.5%, with 5% responding “do not review”. Multiple choice with multiple answers pertaining to thrombolysis decision making; 7.3% reported working autonomously, 29.3% with physician collaboration by telephone, 63.4% with physician at bedside, and 17.1% reported no involvement with thrombolysis decisions. Delineation of responsibilities, also completed with multiple answers included acute inpatient stroke care for 95.2%, out patient stroke care for 23.8%, discharge planning 45.2%, stroke coordinator role 71.4%, core measure database extraction for 50.0% with input of database completed by 47.6%. Education conducted for patients at 81%, for nursing was 90.5%, for peers at 57.1%, for medical residents 40.5%, for neurology residents 16.7% and for community education 73.8% of responders. Conclusion: Although individual responsibilities may vary, the survey illustrates the CNS-NP-PA are valuable roles in the assessment, diagnosis, management, coordination and continuum of stroke care. More research is warranted to further evaluate these roles and quality stroke patient outcomes.
Abstract 3694: Competing Risk for Long-Term Mortality in Patients with Unruptured Intracranial Aneurysm
Introduction: Mortality in patients with unruptured intracranial aneurysm (UIA) is significantly higher than the general population. However a minority of the deaths are due to subarachnoid hemorrhage. Hypothesis: There are differential characteristics of patients that might predict specific causes of death that would be informative in counseling patients about aneurysm risk. Methods: 4059 patients with UIA who were enrolled prospectively between 1991 and 1998 were followed by 61 medical centers in North America, Canada, and Europe. Patients have at least one UIA, which may or may not be symptomatic. Patients were Rankin grade 1 or 2 at enrollment. Patients were followed annually from enrollment to 2007. For patients who died a death certificate search was done and information was requested from local physicians and other contacts. A National Death Index search in 2008 determined cases who died and cause of death. Foreign centers also did a national search where possible. Patients who died before 30 days post treatment or lost to follow up before 30 days post enrollment were excluded. Results: Twenty-five percent of patients died during follow-up. The life expectancy was significantly less than age-, sex-, and country-matched expected estimates. Among the total of 4004 patients with UIA who survived 30 days after enrollment, 2331 were treated and 1673 were not. There were 965 deaths after 30 days after treatment, of which 320 died from vascular disease (252 died from non-SAH vascular disease), 114 died from respiratory tract disease, 255 died from cancer, and the rest died of other or unknown reasons. Predictors of SAH death were aneurysm size, site, age and convulsive disorders at enrollment. Factors related to vascular death were UIA treatment, age, gender, race, hypertension, Rankin at discharge and diminishing influence of aneurysm characteristics over time. Respiratory deaths were related to treatment, race, smoking, age, initial Rankin and presentation with convulsive disorder. Cancer deaths were related to gender, race, smoking and age. Conclusions: In patients with UIA, an assessment of risk for death underscores the importance of age, race and gender and several modifiable risk factors. Patient management should include not only aneurysm rupture prevention but also modification of smoking and hypertension.
Abstract 3629: Validation of the Prognostic Value of Quantitative Brain Diffusion-Weighted Imaging after Cardiac Arrest in a Multi-Center Study. Preliminary results
Background: Brain diffusion-weighted imaging MRI (DWI) holds promise as a prognostic tool in comatose post-cardiac arrest patients. In a preliminary study we found that more than 10% of whole brain volume with an ADC value of <650x10 -6 mm 2 /sec between 49-108 hours after the arrest identified poor outcome patients (death or vegetative state at 30 days) with 100% specificity and 81% sensitivity. We aimed to validate this threshold in an external dataset. Methods: This is an ongoing multicenter observational study of DWI MRIs of comatose post-cardiac arrest patients obtained between 1 and 5 days (i.e. 25-120 hours) after the arrest. Patient data are systematically recorded on a web-based data entry form and include baseline characteristics, serial neurological examinations, neurophysiological testing, and date and cause of death if applicable. Poor outcome is defined as in hospital death. Assuming a 40% survival rate, and 100% specificity of DWI for poor outcome, 250 patients are needed to achieve a 0% false positive rate for poor outcome with a 95% confidence interval of 0-5%. MRI scans were processed using MIPAV (Medical Image Processing, Analysis and Visualization program). The brain was semi-automatically outlined on the b0 images using a levelset algorithm that analyzes the intensity and then produces the contours of the boundary. If necessary, contours were adjusted manually. The created brain masks were then applied to the corresponding ADC maps, and the ADC values of voxels within the brain were saved for further analysis. We used the ADC maps that we received from the participating centers. If only the b0 and b1000 images were available, we recreated the brain ADC maps using MIPAV. Results: Data from 48 patients from three centers (Northwestern, Mayo Clinic Jacksonville, Stanford) were included in this preliminary analysis: mean age was 57±16 years, 33% female, arrest time 23±23 minutes, 88% of patients were treated with hypothermia. The MRIs were obtained at 73±22 hours after the arrest. Twenty patients (42%) survived to hospital discharge. The median (IQR) percentage of brain volume with ADC<650x10 -6 mm 2 /sec was 5% (3-6) in survivors and 30% (9-46) in non-survivors (P<0.001). Brain volume with an ADC<650x10 -6 mm 2 /sec > 10% was 100% (95%CI 80-100) specific and 68% (95%CI 48-83) sensitive for in hospital death with a positive predictive value of 100% (79-100), and a negative predictive value of 69% (49-84). The risk ratio (RR) of death if >10% of brain volume had an ADC<650x10 -6 mm 2 /sec was 3.2 (95%CI 1.9-5.5). Conclusion: The preliminary results of this multicenter study demonstrate that early quantitative DWI MRI in comatose post-cardiac arrest patients holds great promise as a prognostic adjunct in these patients in the era of hypothermia. Centers who frequently obtain brain DWI MRI in comatose post-cardiac arrest patients are encouraged to participate.
Abstract 3196: Effect Of Marital Status On Health-seeking Behavior Following Onset Of Acute Stroke Symptoms
Background: Each year, nearly 700,000 Americans suffer from strokes, resulting in 150,000 deaths and significant disability among survivors. Despite advances in therapeutic options for acute stroke within a critical time window, patient delay in seeking medical attention remains a significant barrier to improving outcomes. In a recent study of the effect of marital status on the timing of presentation for medical care in patients with chest pain, married men presented earlier than married women. In this study, we hypothesize that marital status is a predictor of earlier health-seeking behavior following the onset of stroke symptoms. Methods: We conducted a retrospective review of 100 patients with acute stroke symptoms in our stroke alert quality initiative database who were brought by Emergency Medical Services (EMS) to the Mayo Clinic Hospital, Arizona between December 1, 2010 and June 30, 2011. Nine patients were excluded due to lack of data. The database contains the following information for each patient: age, gender, marital status, the time of symptom awareness, and the time of EMS dispatch. Using both an independent samples t-Test and ANOVA, we compared the time from symptom awareness to EMS dispatch both between married and single patients, and between men and women, (married and single). Results: The mean age of the 91 patients studied was 76 years (SD = 12.5 years) and 52% were women. Forty-five patients (49.5%) were married, and 46 (50.5%) were single. The mean time from symptom awareness to EMS activation was 52 minutes (median 21.0, SD 87.3, range 2-519 minutes.) Categorized by marital status, married patients activated EMS earlier that single patients, but this difference was not significant (43 versus 60 minutes, p=0.35.). Analyzing the data separately for gender, we found that married men activated EMS significantly earlier than married women (26 versus 72 minutes, p=0.04.). Single men activated EMS earlier than single women, but this difference was not significant (50 versus 66 minutes, p=0.60.) Conclusions: Among persons with acute stroke symptoms, earlier medical-seeking behavior was seen in married compared to single persons, and particularly in married men. We plan to analyze a larger sample of patients, and if these preliminary findings are confirmed, we will conduct a prospective study evaluating reasons why married men with stroke symptoms seek medical attention earlier.
Abstract 3155: Hospitalization Costs for Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis in the United States are Substantially Higher than Medicare Payments
Background and Purpose- IV rt-PA has become a widely accepted treatment for a select group of patients with acute ischemic stroke. Quantifying the costs of hospitalization is important for understanding the economic impact of these patients on the hospitals that care for them. We evaluated recent data to determine costs associated with hospitalization for acute ischemic stroke patients treated with intravenous thrombolysis, including subgroup analysis to determine the effects of age and discharge status on hospital costs. Methods- Using the National Inpatient Sample, we evaluated the costs for hospitalization for patients treated with intravenous thrombolysis for acute ischemic stroke in the United States from 2001-2008. The primary endpoint examined in this study was total hospital costs, and these were correlated with clinical outcome. Costs were compared with 2008 Medicare reimbursement for intravenous thrombolysis without complication, and intravenous thrombolysis with major complication. Results- A total of 63472 patients received intravenous thrombolysis for acute ischemic stroke. 24094 patients were <65 years old and 40780 patients were ≥65 years old. Median hospital costs in 2008 dollars were $14102 (IQR $9987-$20819) for patients with good outcome, $18856 (IQR $13145-$30423) for patients with severe disability, and $19129 (IQR $11966-$30781) for patients with mortality. Average 2008 Medicare payments were $10,098 for intravenous thrombolysis without complication and $13,835 for intravenous thrombolysis with major complication. Conclusions- Our study of the NIS shows that hospitalization costs in the United States for ischemic stroke patients treated with intravenous thrombolysis are rather high. Medicare payments have not been adequate reimbursement for these hospitalizations. Hopefully, future reconciliation of costs with payments will be feasible, so that hospitals can afford to provide proper care for ischemic stroke patients treated with intravenous thrombolysis.